Attached files
| file | filename |
|---|---|
| EX-31.4 - EXHIBIT 31.4 - Anika Therapeutics, Inc. | exh_314.htm |
| 10-Q/A - FORM 10-Q/A - Anika Therapeutics, Inc. | f10qa_073120.htm |
Exhibit 31.3
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Cheryl Blanchard, certify that:
| 1. | I have reviewed this Amendment No. 1 on Form 10-Q/A for the quarterly period ended March 31, 2020 of Anika Therapeutics, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| Date: August 6, 2020 | /s/ CHERYL BLANCHARD |
| Cheryl R. Blanchard, Ph.D. | |
| President and Chief Executive Officer | |
| Principal Executive Officer |